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Abstract
Background: Alternative splicing is an important cellular mechanism that can be analyzed by RNA sequencing.
However, identification of splicing events in an automated fashion is error-prone. Thus, further validation is required
to select reliable instances of alternative splicing events (ASEs). There are only few tools specifically designed for
interactive inspection of ASEs and available visualization approaches can be significantly improved.
Results: Here, we present Manananggal, an application specifically designed for the identification of splicing events
in next generation sequencing data. Manananggal includes a web application for visual inspection and a command
line tool that allows for ASE detection. We compare the sashimi plots available in the IGV Viewer, the DEXSeq
splicing plots and SpliceSeq to the Manananggal interface and discuss the advantages and drawbacks of these
tools. We show that sashimi plots (such as those used by the IGV Viewer and SpliceSeq) offer a practical solution
for simple ASEs, but also indicate short-comings for highly complex genes.
Conclusion: Manananggal is an interactive web application that offers functions specifically tailored to the
identification of alternative splicing events that other tools are lacking. The ability to select a subset of isoforms
allows an easier interpretation of complex alternative splicing events. In contrast to SpliceSeq and the DEXSeq
splicing plot, Manananggal does not obscure the gene structure by showing full transcript models that makes it
easier to determine which isoforms are expressed and which are not.
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Background
Eukaryotic transcripts share features with a vampire-like
creature of Philippine mythology: the Manananggals,
nocturnal creatures that prey on pregnant women and
feed on the blood and hearts of fetuses. These creatures
have the ability to split their torso into two parts, which
allows the upper part to fly into the night to go hunting
while the vulnerable lower part remains stationary.
Whereas transcripts do not share the Manananggal’s lust
for blood and hearts, they are able to reshape themselves
by losing parts of their substance. This process, called
“splicing”, rips out some introns and exons to generate
new transcripts that translate into proteins with poten-
tial distinct functions. Aside from some exceptions, most
transcripts depend on additional proteins (splice factors)
for efficient splicing. We call the ability to generate a
multitude of isoforms from a single genomic locus alter-
native splicing (AS). It is accomplished by skipping
whole exons, using alternative splice acceptor and donor
sites or retaining introns.
Splicing allows cells to increase the number of poten-
tially functional RNAs and proteins without increasing
the size of the genome. The current GENCODE [1] gene
annotation (v23) for the human genome includes more
than three times as many transcripts than genes (60,498
genes; 198,619 transcripts). Evidence has been gathered
for the involvement of alternative splicing in neuro-
logical disorders (e.g. autism [2], Huntington’s disease
[3], spinal muscular atrophy [4]), autoimmune diseases
(e.g. multiple sclerosis [5], systemic lupus erythematosus
[6], Kawasaki disease [7]) and tumorigenesis [8–11].
Understanding this aberrant splicing behavior could
translate into a health benefit for patients.
The advent of next-generation sequencing (NGS), and
in particular RNA sequencing (RNASeq), simplified the
detection and quantification of splicing events in a broad
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range of genes in a single experiment and a number of
tools have been developed for this task.
Some assess alternative splicing by assigning reads to
complete isoforms based on statistical models (Cufflinks
[12], MMSEQ [13]), while other tools focus on single
exon coverage (e.g. DEXSeq [14]) or a combination of
junction-spanning reads and exon coverage (e.g. MATS
[15]). To circumvent the problem of incomplete annota-
tion, tools like Cufflinks, Trinity [16] and Trans-ABySS
[17] perform a genome-guided or de novo assembly of
transcripts. This also allows these tools to identify com-
pletely novel isoforms. Manananggal visualizes novel
splicing events (in known genes) as incomplete isoforms
that are reduced to the putative exon start and exon end
surrounding the novel splice junction(s). However, it
cannot detect completely new genes.
All tools usually generate vast lists of potential alter-
native splicing events between conditions. However, in
many cases these events represent false positives, a
finding that is supported by previously published tool
comparisons that detected little overlap between the
result lists of these tools [18]. Hence, it is strongly ad-
visable to validate alternative splicing events by other
means. Visual inspection of the data can already
strengthen the evidence for an alternative splicing event
without the necessity to validate a large number of
events in the wet lab.
Unfortunately, the few available interactive tools for
visual inspection of alternative splicing in RNASeq data
are scarce and in most cases not flexible enough to get a
good visualization of the splicing events and the involved
isoforms. Therefore, we developed Manananggal, a web
application designed to facilitate the visual inspection of
alternative splicing events.
Implementation
Manananggal was implemented in Java using the freely
available community edition of the ZK framework. A
server is required to deploy the application and a config-
uration file for the server must be prepared to specify
where Manananggal finds reference and project data.
Each sample of a project requires two input files: a big-
wig file and a junction count file that must be specified
in a project file along with some metadata. The user
manual that comes with Manananggal explains how
these files can be obtained. For internal calculations,
Manananggal relies on size factors to adjust for differ-
ences in the library size. The size factors can be gener-
ated using the command line tool that is included in the
Manananggal.jar file (also explained in the user manual).
Alternatively, users may add their own size factor esti-
mates (e.g. from DEXSeq [14]) to the project file.
When a data set is opened and a gene is selected in
the web application, the Manananggal method tries to
identify all alternative splicing events in the gene. Can-
didate events are added to a result list in the top right
corner of the web interface. A short overview on how
this algorithm works is shown in Fig. 1.
In brief, the algorithm works as follows: junction count
files are used to calculate PSI scores for each pair of
conditions specified in the project file and bigwig files
are used to identify changes in the coverage ratio of
exons. We used a greedy implementation of the PSI
score that uses only a single junction for measuring the
inclusion count of an exon. The reason behind this is,
that terminal exons (e.g. start or end exons) of a tran-
script are only supported by a single junction and exon
skipping events might refer to exons that are connected
to more than one exon, resulting in an imbalanced count
value for neighboring junctions that could yield wrong
results. We compared our algorithm to other tools such
as rMATS, Cuffdiff and DEXSeq. In our evaluation it
performs comparable to rMATS and DEXSeq and out-
performed Cuffdiff with respect to the detection of alter-
native splicing candidates (Fig. 2, see Additional file 1:
Supplementary Material chapters III to IV for a detailed
comparison of the methods). However, Manananggal is
significantly faster than rMATS and Cuffdiff (Additional
file 1: Table S4) and can thus be used on the fly. Please
refer to the user manual if you would like to run the
Manananggal stand-alone console application to identify
alternative splicing events in your project.
The Manananggal user interface, shown in Fig. 3, of-
fers a wide range of options. Usually, users do not
have to worry about most of them and can just use the
default settings. However, genes with a very large
number of exons might for example require that users
define a larger window width to plot them correctly. A
larger window width can also be used to zoom into
the gene. The interface also offers ways to select or
unselect certain samples (e.g. outliers) and isoforms
(e.g. if they are unexpressed). For each sample group
users may select their own color that is a helpful fea-
ture for people with color deficiency or when certain
colors are generally associated with a certain pheno-
type. Further, an automatically generated list of
predicted alternative splicing events, based on the al-
gorithm described above, provides a comfortable way
to focus on these events. Exon skipping events that
show differences in the exon coverage ratios and PSI
score are also indicated on the meta exon track in the
isoform view, where meta exons are chromosomal
regions defined by the minimum start and maximum
end position of all overlapping exons. Other types of
ASEs are not highlighted because they tend to include
more false positives if unexpressed isoforms are
selected (see Additional file 1: Figure S8 for a more
detailed explanation).
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Another feature provided by Manananggal is the abil-
ity to share your results with others. In the advanced
options window is a button generates HTML links for
the current selections, which includes the selected data
set, gene reference, samples and isoforms. Adding the
keyword “&screenshot” to the URL facilitates sharing of
results when many samples or very large genes are in-
volved. The viewer will generate a screenshot the first
time the link is accessed and load this screenshot for
every subsequent use of the URL. Further, users can rate
and save interesting alternative splicing events to a list
that is automatically loaded whenever someone opens
the same project. This list is located in the top-right cor-
ner of the web interface.
Sometimes it might be important to know in which
tissues a gene or exon is expressed, e.g. when searching
for very specific ASEs. To visualize this information we
provide multiple options, but all of them require that
Fig. 1 Workflow of the Manananggal method. Junction counts are merged to generate one large table with all possible junctions. The table is
indexed for random access and used to identify splice junction pairs that differ between conditions (a). One junction in each pair corresponds to
a junction arguing for the inclusion and another for the exclusion of the exon. All possible inclusion/exclusion junction combinations for an exon
are used to identify the combination that shows the largest difference between conditions. This combination is subsequently used in a t-test to
provide a p-value for sorting of the results. If the best junction pair includes read counts of an unannotated junction we also report the best
available result using only known junctions. The right side of the image illustrates the detection of coverage ratio changes. BigWig files are
used to calculate size factors for each sample that are used to adjust for sequencing depth differences. b An automated isoform selection
discards isoforms that contain exons with insufficient coverage from the analysis. c The arrow indicates an alternatively spliced exon that
shows a large change in the coverage ratio (depicted by dark grey and light grey color for each condition) compared to the remaining exons
(or exon groups). Changes in the coverage ratios between different conditions are identified by testing the coverage ratios of each nucleotide
of the query exon against the mean coverage ratios of the remaining exons/exon groups. d Finally, a result list is generated that contains ASE
candidates that are supported by PSI scores only, ratio changes only, or both
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users have access to tissue specific gene and exon ex-
pression data (e.g. GTEX). Option one opens a boxplot
that shows the expression of the whole gene in all tis-
sues. Option two uses the meta exon track to highlight
tissue specific exonic parts (Fig. 4a) that can be clicked
to open a popup window that shows a boxplot for the
exons expression in all tissues (Fig. 4b).
A more detailed explanation of all the functions is given
in the user manual that can be accessed by clicking on the
“Manual” button located in section B of Fig. 3.
Results
In the following, we will show how Manananggal can be
used to inspect ASEs and discuss its advantages over
other tools. If possible, we tried to use the same data set
and gene for the comparison. We used the prostate can-
cer data set published with the rMATS publication [19]
(Accession number: SRS354082). The data includes
three samples for each of two prostate cancer cell lines
(GS689_Li and PC3E).
One tool that was developed to visualize alternative
splicing is Vials [20]. We used the publically available
online installation of Vials (http://www.vials.io/vials) to
compare its features to Manananggal’s. Since the tool
includes bodymap data, we decided to go for an alterna-
tive splicing event in PKIG between heart and brain that
we will also use for the comparison of another tool later.
According to the GTEX portal and also the tissue spe-
cific data stored in SpliceSeq, different isoforms of PKIG
are expressed in brain and heart that use two different
promoters. Figure 5 shows PKIG in the Vials web inter-
face. The top view shows the frequency of all junctions
in all samples. For demonstration purposes, we selected
the first isoform, which shows all junctions of the iso-
form in wider columns. A larger difference between
brain (blue) and heart (orange) can be observed for the
first junction, which appears to be more frequently
expressed in heart than brain. This data is supported by
the isoform track below that shows isoform expression
estimates to the right. As shown, the first isoform is
more often expressed in heart and the second isoform is
more often expressed in brain. The difference is not so
obvious in the coverage tracks at the bottom, because
the coverage for all samples is shown relative to the
maximum coverage of all tissues, similar to Mananang-
gal. However, Manananggal has an option to unselect
groups or single samples dynamically, while Vials relies
on different source files that define the groups.
Fig. 2 Comparison of detected AS candidates to 41 RT-PCR confirmed AS events. rMATS was originally used by Lu et al. (2014) [24] and Shen et al.
(2014) [19] for the detection of the AS events in the PC-3E and GS689.Li prostate cell lines. They chose 43 AS events and validated 41 by
RT-PCR. For two genes (FN1 and KRAS) the RT-PCR failed and, thus, it is unclear whether they represent real events. All events were identified by
Manananggal. However, several events showed only very small changes (<15%, numbers to the right of rows with exclamation mark). rMATS detected
all events but the exon skipping in SLC37A2 and reported a high FDR for the event in ARFGAP2. DEXSeq detected all events but the one in IGF2BP3
and Cuffdiff failed to detect 17 of these exon skipping events
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Therefore, users can unselect high coverage tissues that
are not of interest in Manananggal and get a clearer pic-
ture of the coverage tracks, which requires additional ef-
fort in Vials. The dot and boxplots of the junction
coverage track are helpful, but also a bit tedious because
you have to compare each isoform to each other and
then decide where the differences are. Instead, one will
usually rely on the isoform expression estimates by
MISO to detect alternatively spliced isoforms and then
check the junctions for these. While this works very well
in this example, isoform expression estimates are often
very wrong for complex genes or when using Gencode,
Fig. 3 Overview of the Manananggal user interface. a Project specific selections, e.g. what condition type should be used for grouping samples.
b options that affect the visual output shown in g and h, also includes a link to the user manual. c Specific samples can be selected here.
d Colors for each condition can be defined here. e Isoforms may be selected here. f Additional options that affect the visual output and
detection of alternatively spliced exons. Also includes a button to create a HTML link to the current view. g Coverage plots that by default show one
coverage line per condition. h The isoform plot indicates overlapping transcripts in sense and antisense direction, highlights potential exon skipping
events and shows each of the selected isoforms. Please note that the image is not showing the complete Manananggal interface. A multi-column
table of alternative splicing candidates is located in the top right corner of the web interface that we omitted for reasons of clarity
Fig. 4 Tissue specific expression. a shows the tissue specificity for exonic parts on the meta exon track. One of the meta exons is colored in red
with a specificity of 0.74. The specificity ranges from 0 (unspecific) to 1 (very specific). b shows the popup window that opens after clicking the
red colored exonic part. It becomes apparent that the exon is almost exclusively expressed in different brain tissues (red boxes)
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which includes also incomplete isoforms. Imagine a gene
with multiple alternative splicing events that don’t allow
for unambiguous isoform expression quantification. In
this scenario MISO estimates are less informative and it
is necessary to identify the alternative splicing change
manually by examining all junctions one by one, which
is very time consuming for large genes. Manananggal on
the other hand is focused on single splicing events and
provides a list of potential splicing events each time a
new gene is opened. This facilitates the identification of
splicing events even for complex genes if you don’t have
prior knowledge of the events of interest. If desired, iso-
form expression estimates can also be shown behind
each isoform in the isoform view of Manananggal that
are generated using MMSeq. Compared to Vials,
Manananggal also offers additional features that Vials
lacks, such as: dynamic coloring of sample groups, direct
comparison of isoform specific junction counts for iden-
tified alternative splicing events, interactive sample se-
lection, merged coverage plots, ability to freely choose
isoforms, saving and sharing the current view via HTML
links, log2 transformation of the coverage, and some
other features.
One very popular tool for visualization of Next-
Generation-Sequencing data is the IGV Viewer. It is a
platform independent application that can visualize a
broad range of data types. For the inspection of ASEs it
includes an option to visualize the data as so called sash-
imi plot [21]. Figure 6 shows an example of such a plot
for an ASE in APLP2. The first three samples (each sam-
ple has a different color) refer to the GS689_Li samples
and the last three to the PC3E samples. For genes with
few isoforms sashimi plots are easy to interpret. In the
example, it is clear that the middle exon is lower
Fig. 5 Vials Visualization of an alternative splicing event in PKIG that uses different promoters in hear and brain. Junction frequencies are shown
at the top, isoforms and MISO isoform expression estimates in the middle and coverage tracks at the bottom
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expressed in the GS689_Li samples than in the PC3E
samples, and the count number of the exclusion junc-
tions supports this as well. However, imagine you have
four different conditions with 10 samples each. This
would result in an enormous plot that would be much
more difficult to interpret. The inability of the IGV viewer
to group samples into a single plot is a big disadvantage
for larger projects. Further, introns are shown to scale,
resulting in very small exons. The list of isoforms at the
bottom is also fixed and removing unexpressed isoforms
is only possible by editing the gene annotation file.
DEXSeq comes with a plot function that could be
combined with web frameworks (such as Shiny) to cre-
ate a somewhat interactive web interface that produces
splicing images for single genes on demand. Figure 7
shows such a plot using the same data set and gene as
before. For easier interpretation we marked two alterna-
tive splicing events that are present in APLP2 by red
rectangles. The first event corresponds to the event
shown for the IGV Viewer. The top of the plot shows
the coverage of exonic parts and the lower part shows a
flattened gene model. The gene track at the bottom indi-
cates differentially spliced exonic parts by adding color
to them. Especially the terminal exons are indicated as
differentially expressed. The advantage of this plot over
the IGV sashimi plot is that it combines the coverage of
all samples within a group and, thus, it can be effectively
used to visually inspect a large number of samples. An-
other plus is that the plot shows all exonic parts at once,
thus, multiple events may be investigated at the same
Fig. 6 Sashimi plot taken from the IGV Viewer that shows an ASE in the gene APLP2. Each different color represents a different sample (the last
track is the gene annotation track). The first three samples represent GS689_Li samples and the last three samples belong to the prostate cancer
cell line PC3E. The plot shows that GS689_Li samples express the middle exon less frequent than PC3E samples. Only junctions with a minimum
read coverage of 100 are shown
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time. The largest disadvantage is the use of exonic parts.
This obscures the true gene structure and makes it very
hard to tell which exonic part belongs to which exon.
Further, the DEXSeq plot does not provide information
on overlapping transcripts that could be the reason of
false positive ASEs.
Next, we tried to produce images for the same gene
using SpliceSeq [22]. Compared to the other tools Spli-
ceSeq cannot use previously mapped data and, thus,
requires fastq files that are then mapped using bowtie.
On a windows computer this process failed for the
whole data set. Using a reduced sequence file (only reads
mapping to the CD44 gene locus) we were able to suc-
cessfully map the data and import it into the SpliceSeq
database. Unfortunately, the program fails at the isoform
generation step for an unknown reason. Without the
source code we could not dig deeper into the problem
and, therefore, decided to discuss an example using the
Fig. 7 DEXSeq’s plot for the visualization of alternative splicing events. Shown at the top is the coverage for both sample groups separately. Each
line corresponds to a single exonic part. The outlined exonic parts are two strong ASEs. The bottom part of the image shows the gene structure
and depicts differentially expressed exonic parts by adding color to the exonic part and the line connecting the exonic part to the x-axis of the
coverage plot. Two alternative splicing events were framed with red rectangles that represent the major ASEs in this gene
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data set that is provided with the tool. Figure 8a shows
an alternative splicing event in PKIG using data from
brain and heart.
The graphical representation is very similar to the IGV
sashimi plots with three important differences. First,
there is only a single graph showing the read counts for
each group that allows the comparison of a large num-
ber of samples. Second, introns are drawn with a fixed
length allowing for the investigation of a much larger
part of the gene at once, and third, alternative splicing
events are highlighted. Disadvantageous are the lack of
coverage plots and a missing indication of overlapping
transcripts that make it difficult to spot problems that
arise from differential expression or antisense transcrip-
tion. Further, the example also shows how this represen-
tation can be very misleading. The highlighted event has
been classified as an ES (exon skipping) event by Splice-
Seq and the visual representation also suggests that this
is an exon skipping event. However, considering the read
numbers it becomes clear that the major event might
not be exon skipping. Another disadvantage of SpliceSeq
is that it is not possible to hide exons that belong to
isoforms that are either absent or very lowly expressed
(e.g. exon 3), thus giving the sashimi plot a more com-
plicated look than would be necessary.
We implemented several improvements over the other
tools in Manananggal. Similar to the DEXSeq plot and
SpliceSeq we combine the data of multiple samples into a
single plot. DEXSeq also showed the per group coverage
for each exonic part but only provides a single coverage
value for each exonic part and does not indicate the range
of the expression. In contrast, Manananggal also shows
the upper and lower quartile of the coverage at each base
position and users can choose between mean or median
representation. Coverage differences between conditions
may be large and, thus, we also provide options to show
the log2 coverage and coverage ratios. Coverage ratio plots
proofed to be very helpful for spotting ASEs. Figure 9
shows the APLP2 splicing event from the prostate cancer
in the Manananggal viewer.
A standard coverage plot is shown at the top, the alter-
native coverage ratio plot in the middle and the isoforms
at the bottom. Colors for each condition may be freely
changed to consider the needs of people with color
Fig. 8 Visual representation of an alternative splicing event in SpliceSeq. a shows the visual representation inside the SpliceSeq viewer. All exons
of the gene are shown in a single line. Overlapping exons are merged into meta exons that indicate which part of the meta exon belong to
which exon. Expression numbers are given for each exonic part and junction. The ASE is highlighted in yellow by SpliceSeq to make users aware
of the elements involved in the splicing event. b shows some of the structure of three PKIG transcripts that were copied from Manananggal to
emphasize that exon 2.1 represents an alternative transcript start. c shows a combined image of the expression of the first and last transcript
shown in b in multiple brain and heart tissues that was obtained from the GTEX portal (http://www.gtexportal.org/). It demonstrates that
ENST00000372886 is expressed in heart and ENST00000372894 in brain
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deficiency. The isoform plot indicates overlapping anti-
sense (AS) and sense (S) transcripts. AS transcripts,
which are absent in this case, are shown in orange (for
non-exonic overlap) and red (exonic overlap). Overlap-
ping transcripts in sense direction are shown in light
blue (non-exonic) and dark blue (exonic). While overlap
to exonic regions of other genes is a frequent origin of
false positive alternative splicing results, overlap with
non-exonic regions usually does not result in false posi-
tive alternative splicing events, but we believe it is help-
ful to make the user aware of a potential overlapping
transcript. The meta exon track indicates potentially
alternatively spliced exons (highlighted in red) and indi-
cates the orientation of the gene. In the picture shown,
uninformative isoforms (i.e. isoforms that are not pro-
viding additional expressed junction paths) were unse-
lected. If available to the server, Manananggal can run
MMSEQ to produce isoform quantifications that will be
displayed at the end of each isoform for each condition.
For large sample sets this can take a long time and
might even exhaust the resources of the server, thus, it
should be carefully considered whether to enable
MMSEQ or not (e.g. working with projects that have
only some dozens of samples should be fine). In contrast
to the DEXSeq plot and SpliceSeq, Manananggal pre-
serves the full transcript structure, thus, making it easier
to tell which exon is actually involved in an ASE.
Although Manananggal provides many abilities that
were tailored to inspect alternative splicing event, all of
the above mentioned tools might be sufficient to visually
inspect simple splicing events, such as the one shown in
APLP2. However, the real strength of Manananggal is
the ability to investigate highly complex genes. Figure 10a
shows the CD44 locus using the IGV Viewer and the
prostate cancer data set (see Additional file 2: Figure S1
for higher resolution images).
By looking at the image it becomes clear that there
is some difference between the GS689_Li samples and
PC3E samples, but it is not possible to decipher what
that difference is. The IGV viewer offers to hide junc-
tions based on a count threshold. Figure 10b (see
Additional file 3: Figure S2.png for higher resolution
images) shows the CD44 region after exon 5, a region
with multiple optional exons, using a junction count
Fig. 9 Visual output for APLP2 from Manananggal. a shows the standard coverage plot for both sample groups. The light shaded regions around
each line represent the upper and lower quartile of the coverage. b shows the coverage ratio representation of the coverage plot. Using ratios
flattens the coverage for all exons and makes it easier to spot the alternatively spliced exons that appear at ‘bumps’ in the coverage ratio that
otherwise remains very constant across all exons. c shows the isoforms that are likely involved in the ASEs. The antisense transcript track is empty
and the sense transcript track only shows one exon of APLP2 that overlaps an intronic region of another transcript on the same strand (indicated
by the light blue box). Therefore, it is unlikely that overlapping transcripts influence the coverage of APLP2, especially at the ASEs. Further, the
automatic ASE detection algorithm of Manananggal identified both ASEs and indicates them by coloring the respective meta exons in red. The
percent numbers at the end of each transcript correspond to MMSEQ isoform expression estimates that can be generated if Manananggal has
access to MMSEQ. However, this also shows that MMSEQ assigned a large fraction of the coverage to other transcripts that are probably less
important or not expressed at all
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threshold of 100. Now it’s much more obvious that
the GS689_Li samples mostly express an isoform that
skips all of the optional exons, while for the PC3E
samples it remains less clear which isoforms are
expressed.
Similar, the DEXSeq plot (Fig. 10c, see Additional file 4:
Figure S3 for higher resolution images) shows nicely that
the GS689_Li samples skip all the optional exons, but it
does not help to identify the isoforms that may be
expressed in PC3E. Figure 10d (see Additional file 5:
Figure S4 for higher resolution images) shows the Spli-
ceSeq representation for CD44 for each sample separ-
ately (as mentioned before, we were unable to run the
isoform generation step and, thus, cannot show the per
group estimates). However, as SpliceSeq does not offer
an option to hide lower expressed junctions, we expect
Fig. 10 Visual representation of CD44 in the IGV Viewer, DEXSeq and SpliceSeq. a shows a sashimi plot of the CD44 gene with all junctions
visible. A difference between the first three (GS689_Li) and last three samples (PC3E) is visible, but it is very challenging to identify which
junctions belong to the ASEs or what ASEs are actually present in the data set. b shows a sashimi plot that was zoomed to the region of interest.
Junctions with a coverage below 100 were hidden from the picture to get a cleaner view of the region. It becomes clear that the GS689_Li
samples mostly skip all optional exons in this region, while CD44 expresses multiple of them. However, it remains difficult to tell which isoforms
are expressed in CD44. c shows the DEXSeq plot for CD44. A large number of exonic parts appear to be differentially expressed. d shows the
sashimi plots for all 6 samples in SpliceSeq. A coverage difference is visible for all optional exons that are lower expressed in the GS689_Li
samples. The PC3E samples show a large number of junctions
Fig. 11 Manananggal’s visual representation of alternative splicing events in CD44. The coverage plot at the top shows that multiple exons are
only expressed in the PC3E samples. These alternatively spliced exons are also highlighted on the meta exon track. One exon appears to have a
higher expression in GS689_Li samples. However, this exon overlaps an exon of an antisense transcript (indicated by the red box on the AS
transcripts track) and thus does not represent a valid alternative splicing event. The isoforms shown at the bottom were selected in a way that
represents the coverage plot best. Please note that some of these isoforms (especially the last two) might represent incomplete transcripts that
are included in the gene reference
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that the combined graph for all samples would look
equally complicated. However, similar to the other
tools, also this example indicates a difference between
the two sample groups, but it just does not provide
enough information to identify the most important
isoforms.
With Manananggal we generated the image shown in
Fig. 11. By removal of probably unexpressed isoforms
(= no read evidence) we limited the number of isoforms
that are obviously expressed in the data set. Compared
to the other tools this image appears much cleaner
without losing information. On the contrary, additional
information becomes visible. The optional exons have
different expression heights, thus, multiple isoforms
must be expressed in the PC3E data set, and one exon
appears to have a larger coverage in the GS689_Li group.
However, an exon of an antisense transcript (indicated by
a red box) is overlapping this exon and, thus, this coverage
difference is very likely not related to an alternative spli-
cing event. Further, the isoforms depicted show the most
important splicing events that are necessary to explain the
coverage pattern. However, one should bear in mind that
not all isoforms included in GENCODE represent full
transcripts, thus, some of the shorter isoforms shown here
probably lack exons.
Discussion
Existing viewers like the Integrative Genomics Viewer
(IGV) [23] provide ways, e.g. Sashimi plots, to investi-
gate alternative splicing, but the representation becomes
very difficult to interpret once multiple samples are in-
vestigated or transcript models are complicated. Splice-
Seq [22] employs a visualization similar to IGV and,
additionally, provides functionality to compare sample
groups. Other programs, like DEXSeq provide single
exon expression charts. While this also works well for
multiple samples, it does not provide the user with
information regarding the junction coverage or known
transcript models.
Conclusions
We developed Manananggal, a novel tool for the
visualization of alternative splicing events that comes
with its own method for AS detection. Compared to
the other tools with similar functions, Manananggal
provides additional features that facilitate this process
(Table 1). Additional features tailored to specific prob-
lems are available in Manananggal (not discussed here).
These features are thoroughly explained in the user manual
that also includes a tutorial section. With Manananggal we
provide the community with a freely available web applica-
tion that can be used by non-experts and experts alike to
get more information on their data.
Availability and requirements
Project name: Manananggal
Project home page: https://github.com/barannm/
Manananggal
Operating system(s): Web application running in any
recent browser
Programming language: Java
Other requirements: Installation requires a Tomcat
Web Server where the application can be hosted
License: GNU AGPLv3
Additional files
Additional file 1: Details about the algorithm behind Manananggal and
detailed comparisons of the method to other tools. (DOC 4064 kb)
Additional file 2: Figure S1. Additional figure showing the example of
CD44 alternative splicing visualized in IGV. (PNG 430 kb)
Additional file 3: Figure S2. Additional figure showing the example of
CD44 alternative splicing visualized in IGV (zoom in). (PNG 125 kb)
Table 1 Comparison of Manananggal to other visualization methods for alternative splicing events
Manananggal IGV SpliceSeq DEXSeq
Input BIGWIG + COUNT_FILE BAM fastq BAM
Organism Human/Mousea All All? All
Interactive ✓ ✓ ✓ (✗)
Unexpressed isoforms can be hidden ✓ ✗ ✗ (✗)
Coverage plots are available to spot differential expression ✓ ✓ ✗ ✓
Indication of overlapping antisense transcripts ✓ ✓ ✗ (✗)
gene/transcript structure full full reduced reduced
introns compressed to scale compressed to scale
Indicates AS exons ✓ ✗ ✓ ✓
Allows group comparisons ✓ ✗ ✓ ✓
aIn principle Manananggal should also work with other organisms. Some functions, such as the cross-reference table are not available for other organisms and
thus users would need to use gene IDs rather than symbols to query genes
The DEXSeq plot is an R function that could be modified to add some of the missing features
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Additional file 4: Figure S3. Additional figure showing the example of
CD44 alternative splicing visualized using SpliceSeq. (PNG 212 kb)
Additional file 5: Figure S4. Additional figure showing the example of
CD44 alternative splicing visualized in DEXSeq. (PNG 303 kb)
Abbreviations
AS: Alternative splicing; ASE: Alternative splicing event; NGS: Next-
Generation-Sequencing; RNASeq: RNASequencing
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